
Få fuld adgang til dig og dine kollegaer.
Start et gratis virksomhedsprøveabonnementAllerede abonnent? Log Ind.
A number of US pharmaceutical companies have stopped their trials with the enzyme IDO after a US company failed in phase 3, but it does not scare Danish IO Biotech that works with the same enzyme as the company has a different approach than the US companies.
Allerede abonnent? Log Ind.